- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dipeptidyl Peptidase IV inhibitors
Total 1747 results
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Germany
-
Novartis PharmaceuticalsCompletedEfficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 DiabetesDiabetes Mellitus, Type 2Switzerland
-
NovartisCompletedPrediabetic StateUnited States
-
NovartisCompletedType 2 Diabetes MellitusGermany
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Philippines, India, Puerto Rico, Canada, Malaysia, Romania, Slovakia
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
Royal Devon and Exeter NHS Foundation TrustNovartis Pharmaceuticals; National Institute for Health Research, United KingdomCompletedInsulin Resistance | Microvascular DiseaseUnited Kingdom
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusEgypt
-
University of Campania "Luigi Vanvitelli"CompletedChronic Foot UlcersItaly
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusUnited Kingdom
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...CompletedDiabetes Mellitus, Type 2 | Diabetic Ketoacidosis | Lower Extremity Amputation | UrosepsisCanada
-
NovartisTerminatedDiabetes Mellitus, Type 2United States
-
Johann Wolfgang Goethe University HospitalWithdrawnSDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV InhibitorsGermany
-
NovartisCompletedDiabetes Mellitus, Type 2Germany
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Germany
-
NovartisCompletedDiabetes Mellitus, Type 2
-
NovartisCompleted
-
Brigham and Women's HospitalCompleted
-
University of PadovaCompletedType 2 DiabetesItaly
-
Nanjing Medical UniversityUnknown
-
Brigham and Women's HospitalCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
Rio de Janeiro State UniversityLaboratory for Clinical and Experimental Research on Vascular BiologyCompleted1- Microvascular Function | 2-oxidative Stress | 3-inflammationBrazil
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Japan
-
NovartisCompletedType 2 Diabetes Mellitus | ElderlyFrance
-
NovartisCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Mayo ClinicNovartis PharmaceuticalsCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
NovartisCompletedType-2 DiabetesGermany, United States
-
NovartisCompletedHealthy | Type-2 DiabetesGermany
-
University Hospital, ToulouseNovartis Pharmaceuticals; Institute of Molecular Medicine of Rangueil (I2MR); Faculty of Medicine, ToulouseCompletedDiabetes MellitusFrance
-
Brigham and Women's HospitalCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Germany, Switzerland
-
Centre Hospitalier Universitaire de BesanconUniversity Hospital, Strasbourg, France; Centre Hospitalier Universitaire de... and other collaboratorsRecruitingDiabetes | Disorder Related to Renal TransplantationFrance
-
NovartisCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencySpain, Canada, France, Germany, Australia, Costa Rica, Finland, Russian Federation, Argentina, India, Norway, Sweden
-
NovartisCompletedDiabetes Mellitus, Type 2Spain, Argentina, Russian Federation, Norway, India, Sweden, Finland, France, Canada, Germany, Australia, Costa Rica
-
NovartisCompletedDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsTerminatedType 2 Diabetes MellitusMexico
-
University Hospital, Strasbourg, FranceNovartisCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Taiwan
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusChina, Thailand, Philippines, Singapore
-
JW PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Lund UniversityCompletedHypoglycemia | DiabetesSweden
-
Institut fur Diabetesforschung, Munich, GermanyUnknownInsulin-dependent Gestational DiabetesGermany